Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Melanoma-educated CD14+ cells acquire a myeloid-derived suppressor cell phenotype through COX-2-dependent mechanisms.

Cancer research - 1 Jul 2013

Mao Yumeng, Poschke Isabel, Wennerberg Erik, Pico de Coaña Yago, Egyhazi Brage Suzanne, Schultz Inkeri, Hansson Johan, Masucci Giuseppe, Lundqvist Andreas, Kiessling Rolf

Abstract excerpt

Tumors can suppress the host immune system by employing a variety of cellular immune modulators, such as regulatory T cells, tumor-associated macrophages, and myeloid-derived suppressor cells (MDSC). In the peripheral blood of patients with advanced stage melanoma, there is an accumulation of CD1...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Coculture Techniques
Share to Cyclooxygenase 2
Share to Dinoprostone

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immune Tolerance

Share to Leukocytes, Mononuclear

Share to Lipopolysaccharide Receptors

Share to Myeloid Cells

Share to STAT3 Transcription Factor

Source

Identifiers

PMID: 23633486
DOI: 10.1158/0008-5472.CAN-12-4115

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23633486-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Melanoma-educated CD14+ cells acquire a myeloid-derived suppressor cell phenotype through COX-2-dependent mechanisms.PMID 23633486Read ↗

MIF Is Necessary for Late-Stage Melanoma Patient MDSC Immune Suppression and Differentiation.Semantic proximity Read ↗

Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine.Semantic proximity Read ↗

High expression of ID1 in monocytes is strongly associated with phenotypic and functional MDSC markers in advanced melanoma.Semantic proximity Read ↗

Myeloid-Derived Suppressor Cells.Semantic proximity Read ↗

Melanoma‐derived conditioned media efficiently induce the differentiation of monocytes to macrophages that display a highly invasive gene signatureSemantic proximity Read ↗

Melanoma patients with immune-related adverse events after immune checkpoint inhibitors are characterized by a distinct immunological phenotype of circulating T cells and M-MDSCs.Semantic proximity Read ↗

Dynamic CD8+ T Cell Cooperation with Macrophages and Monocytes for Successful Cancer ImmunotherapySemantic proximity Read ↗

CD244 regulates both innate and adaptive immune axes in melanoma by inhibiting autophagy-mediated M1 macrophage maturationSemantic proximity Read ↗

Effective induction of melanoma-antigen-specific CD8+ T cells via Vγ9γδT cell expansion by CD56(high+) Interferon-α-induced dendritic cells.Semantic proximity Read ↗

Decitabine suppresses MDSC-induced immunosuppression through dual functional mechanism and inhibits melanoma metastasisSemantic proximity Read ↗

Myeloid Cells and Related Chronic Inflammatory Factors as Novel Predictive Markers in Melanoma Treatment with Ipilimumab.Semantic proximity Read ↗

Tumor-reactive CD8+ early effector T cells identified at tumor site in primary and metastatic melanoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.